MedX Health Corp (MDXHF)
- Business Wire
MedX Announces Proposed Non-Brokered Private Placement to Raise up to $2,000,000 and Provides an Update on Amendment to Series I Convertible Notes
MISSISSAUGA, Ontario, May 01, 2024--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,000,000 by way of a Non-Brokered Private Placement of up to 28,571,428 Units at $0.07 per Unit ("Unit"). A Price Reservation Form for this proposed placement was filed with the TSXV on April 19, 2024. Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Commo
- Business Wire
MedX Health and Health Partners announce the successful results of its pilot project in the United Kingdom and move towards a partnership agreement
MISSISSAUGA, Ontario, February 28, 2024--MedX Health Corp. ("MedX" or the "Company") (TSXV: MDX), a global leader in teledermatology, is pleased to announce they have successfully completed the pilot project with Health Partners. MedX and Health Partners are working together to begin the roll-out of this service to targeted clients engaged in a preventative approach to health care management.
- Business Wire
MedX Health Corp. announces Dr. Paul Cohen as Medical Spokesperson
MISSISSAUGA, Ontario, January 25, 2024--MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and Fellow of the Royal College of Physicians and Surgeons of Canada, as Medical Spokesperson. Dr. Cohen is also a diplomat of the American Board of Dermatology and is a member of numerous associations, including the Canadian Dermatological Association and the Toronto Dermatological Society. He was awar
